×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Balloon Expandable Stent Market

ID: MRFR/MED/34182-HCR
100 Pages
Rahul Gotadki
October 2025

Balloon Expandable Stent Market Research Report By Application (Coronary Artery Disease, Peripheral Artery Disease, Valve Replacement), By Type (Drug-Eluting Stents, Bare-Metal Stents, Bioresorbable Stents), By Material (Metal, Polymer, Composite), By End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Balloon Expandable Stent Market Infographic
Purchase Options

Balloon Expandable Stent Market Summary

As per MRFR analysis, the Balloon Expandable Stent Market Size was estimated at 4.8 USD Billion in 2024. The Balloon Expandable Stent industry is projected to grow from 4.979 USD Billion in 2025 to 7.182 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 3.73 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Balloon Expandable Stent Market is poised for growth driven by technological advancements and increasing disease prevalence.

  • Technological advancements in stent design are enhancing the efficacy and safety of procedures.
  • North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region.
  • Coronary artery disease represents the largest segment, whereas valve replacement is witnessing rapid growth.
  • The increasing prevalence of cardiovascular diseases and regulatory support are key drivers of market expansion.

Market Size & Forecast

2024 Market Size 4.8 (USD Billion)
2035 Market Size 7.182 (USD Billion)
CAGR (2025 - 2035) 3.73%

Major Players

Abbott Laboratories (US), Boston Scientific Corporation (US), Medtronic plc (IE), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Cardinal Health, Inc. (US), Cook Medical Incorporated (US), Johnson & Johnson (US)

Balloon Expandable Stent Market Trends

The Balloon Expandable Stent Market is currently experiencing notable growth, driven by advancements in medical technology and an increasing prevalence of cardiovascular diseases. The demand for minimally invasive procedures has surged, as healthcare providers seek to enhance patient outcomes while reducing recovery times. This trend is further supported by ongoing research and development efforts aimed at improving stent designs, materials, and delivery systems. As a result, the market landscape is evolving, with a focus on innovative solutions that cater to diverse patient needs. Moreover, the competitive dynamics within the Balloon Expandable Stent Market are shifting, as new entrants and established players alike strive to capture market share. Collaborations between medical device manufacturers and healthcare institutions are becoming more common, fostering an environment conducive to innovation. Regulatory bodies are also playing a crucial role in shaping the market, as they establish guidelines that ensure safety and efficacy. Overall, the Balloon Expandable Stent Market appears poised for continued expansion, driven by technological advancements and a growing emphasis on patient-centered care.

Technological Advancements

The Balloon Expandable Stent Market is witnessing rapid technological innovations that enhance stent performance and patient safety. New materials and designs are being developed to improve biocompatibility and reduce the risk of complications. These advancements are likely to lead to better clinical outcomes and increased adoption of balloon expandable stents.

Rising Cardiovascular Disease Incidence

The prevalence of cardiovascular diseases is on the rise globally, which is significantly impacting the Balloon Expandable Stent Market. As more individuals are diagnosed with conditions requiring stenting procedures, the demand for effective treatment options is expected to grow, driving market expansion.

Regulatory Developments

Regulatory frameworks are evolving to keep pace with innovations in the Balloon Expandable Stent Market. Stricter guidelines and approval processes are being implemented to ensure the safety and efficacy of new products. This trend may influence market dynamics, as companies adapt to meet regulatory requirements while striving for innovation.

Balloon Expandable Stent Market Drivers

Rising Healthcare Expenditure

The Balloon Expandable Stent Market is positively impacted by the increasing healthcare expenditure observed in various regions. As countries allocate more resources to healthcare, there is a corresponding rise in the availability and accessibility of advanced medical technologies, including balloon expandable stents. This trend is particularly evident in emerging markets, where healthcare investments are expanding rapidly. The increased funding allows for the adoption of innovative stenting solutions, which can improve patient outcomes and reduce long-term healthcare costs. Consequently, the Balloon Expandable Stent Market is expected to thrive as healthcare systems prioritize investments in effective cardiovascular treatments.

Regulatory Support and Approvals

The Balloon Expandable Stent Market benefits from favorable regulatory environments that facilitate the approval of new stent technologies. Regulatory bodies are increasingly recognizing the importance of innovative stenting solutions in improving patient care. For instance, streamlined approval processes for novel stent designs have been implemented, allowing manufacturers to bring their products to market more efficiently. This regulatory support is crucial, as it encourages investment in research and development, leading to the introduction of advanced balloon expandable stents. Consequently, the Balloon Expandable Stent Market is poised for growth, as new products enter the market and meet the evolving needs of healthcare providers.

Technological Advancements in Stent Design

The Balloon Expandable Stent Market is experiencing a notable transformation due to rapid technological advancements. Innovations in materials and design have led to the development of stents that are more durable and biocompatible. For instance, the introduction of drug-eluting balloon stents has shown promise in reducing restenosis rates. Furthermore, advancements in imaging technologies, such as intravascular ultrasound, enhance the precision of stent placement, thereby improving patient outcomes. The market is projected to grow at a compound annual growth rate of approximately 7% over the next five years, driven by these technological improvements. As healthcare providers increasingly adopt these advanced stents, the Balloon Expandable Stent Market is likely to witness significant growth.

Increasing Prevalence of Cardiovascular Diseases

The Balloon Expandable Stent Market is significantly influenced by the rising prevalence of cardiovascular diseases. According to recent data, cardiovascular diseases account for a substantial portion of global mortality rates, prompting a surge in demand for effective treatment options. The World Health Organization estimates that by 2025, cardiovascular diseases will be responsible for nearly 30% of all deaths worldwide. This alarming trend is driving healthcare systems to invest in advanced stenting solutions, including balloon expandable stents, to manage these conditions effectively. As a result, the Balloon Expandable Stent Market is expected to expand rapidly, with an increasing number of procedures being performed annually.

Aging Population and Demand for Minimally Invasive Procedures

The Balloon Expandable Stent Market is also driven by the aging population, which is more susceptible to cardiovascular diseases. As individuals age, the incidence of conditions requiring stenting, such as coronary artery disease, increases. Moreover, there is a growing preference for minimally invasive procedures among patients and healthcare providers alike. Balloon expandable stents are often associated with shorter recovery times and reduced hospital stays, making them an attractive option for both parties. This demographic shift is likely to propel the Balloon Expandable Stent Market forward, as more patients seek effective and less invasive treatment options.

Market Segment Insights

By Application: Coronary Artery Disease (Largest) vs. Valve Replacement (Fastest-Growing)

In the Balloon Expandable Stent Market, Coronary Artery Disease (CAD) applications lead the way with the largest share, as CAD remains a significant health concern globally. This segment is driven by the increasing incidence of coronary artery diseases and the rising adoption of innovative stenting technologies that improve patient outcomes. Peripheral Artery Disease (PAD) applications follow, but the focus on CAD continues to dominate the market landscape, shaped by advancements in medical procedures and patient management strategies.

Coronary Artery Disease (Dominant) vs. Valve Replacement (Emerging)

The Coronary Artery Disease segment plays a crucial role in the Balloon Expandable Stent Market, characterized by its established position and reliance on well-accepted clinical practices. This segment benefits from ongoing research and development efforts, which enhance stent design and delivery mechanisms, leading to improved procedural success rates. On the other hand, the Valve Replacement segment is emerging rapidly, fueled by innovations in transcatheter techniques and an increasing patient base seeking less invasive options. While Valve Replacement shows potential for rapid growth due to changing demographics and technological advancements, CAD remains the dominant force due to its established therapeutic pathways and substantial clinical evidence supporting the use of balloon expandable stents.

By Type: Drug-Eluting Stents (Largest) vs. Bare-Metal Stents (Fastest-Growing)

In the Balloon Expandable Stent Market, the Drug-Eluting Stents (DES) segment holds the largest market share due to their effective drug delivery system that reduces the risk of restenosis. These stents are widely recognized for their role in enhancing patient outcomes and promoting long-term success rates. Conversely, Bare-Metal Stents (BMS) have been regaining traction in recent years as a cost-effective alternative, especially in specific patient subsets who may not require the advanced capabilities of drug-eluting options. In this competitive landscape, the BMS segment is experiencing a strong resurgence as healthcare providers seek more accessible treatment options without compromising safety.

Drug-Eluting Stents (Dominant) vs. Bare-Metal Stents (Emerging)

Drug-Eluting Stents (DES) are recognized as the dominant product in the Balloon Expandable Stent Market, attributed to their superior ability to deliver drugs that prevent the renarrowing of arteries post-implantation. This segment has been propelled by ongoing innovations in drug formulations and stent designs, resulting in improved patient outcomes. On the other hand, Bare-Metal Stents (BMS) are emerging strongly, particularly as healthcare systems advocate for cost-effective solutions with lower upfront costs. Their simplicity and effectiveness in less complex cases make them appealing, especially amid rising healthcare costs. As a result, the BMS segment is increasingly positioned as a viable option for specific patients, leading to its rapid growth.

By Material: Metal (Largest) vs. Polymer (Fastest-Growing)

In the Balloon Expandable Stent Market, the material segment exhibits a diverse distribution among Metal, Polymer, and Composite options. Metal stents dominate the market share, attributed to their proven reliability and strength. With extensive clinical usage, metal stents, including stainless steel and cobalt-chromium variants, hold a significant position, often preferred by healthcare professionals. In contrast, polymer-based stents are experiencing rapid growth, driven by advancements in materials science and an increasing preference for biocompatibility and flexibility in vascular interventions. Growth trends indicate a shift towards innovative polymer stents that offer enhanced graphing and reduced thrombosis risk, contributing to their rising market share. The demand for less invasive procedures and increased patient comfort is encouraging manufacturers to invest in polymer research and development. As the healthcare landscape evolves, the Polymer segment stands out as the fastest-growing sector, potentially revolutionizing treatment approaches in the upcoming years.

Metal (Dominant) vs. Polymer (Emerging)

The Metal segment remains the dominant player in the Balloon Expandable Stent Market, characterized by its proven performance, durability, and structural integrity. Metal stents, especially those made from cobalt-chromium and stainless steel, provide the necessary support to maintain vessel patency, ensuring effective treatment outcomes. The widespread adoption of these stents in clinical settings reinforces their market standing. Conversely, the Polymer segment, while emerging, is gaining traction due to its advantageous properties like flexibility, reduced thrombus formation, and potential for drug-eluting capabilities. Innovations in polymer technology are yielding stents that are less rigid and more adaptable to the dynamic nature of blood vessels, making them an attractive alternative for patient-centric approaches. As these materials evolve, the market potential for polymer stents is substantial, indicating a shift in preferences towards these innovative medical devices.

By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Balloon Expandable Stent Market, hospitals hold the largest market share among the end-use segments, primarily due to their extensive resources and capabilities in performing complex procedures. They are equipped with advanced medical technology and highly skilled personnel, contributing to the high volume of stent placements. Ambulatory Surgical Centers (ASCs), on the other hand, are emerging as significant players, poised for rapid growth in the coming years as they offer more accessible and cost-effective options for patients requiring stent procedures. The increasing preference for minimally invasive surgeries and outpatient procedures is driving the growth of ambulatory surgical centers. ASCs are becoming the choice for many patients and physicians, as they provide convenience and lower costs without compromising on the quality of care. Additionally, the rising prevalence of cardiovascular diseases is propelling demand in both hospitals and ASCs, fostering a competitive landscape where ASCs are expected to grow faster than traditional hospital settings.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals maintain a dominant position in the Balloon Expandable Stent Market, attributed to their comprehensive infrastructure and ability to handle complex cardiovascular cases. They are pivotal in providing advanced care and are typically equipped with the latest medical technologies, ensuring high success rates for stent placements. In contrast, Ambulatory Surgical Centers are emerging rapidly, capitalizing on the trend toward less invasive treatment options. ASCs offer a streamlined patient experience and are increasingly favored for elective procedures due to lower overhead costs. This shift highlights a growing preference for quicker recovery and minimal hospital stays, influencing both patient choices and medical provider strategies.

Get more detailed insights about Balloon Expandable Stent Market

Regional Insights

North America : Market Leader in Innovation

North America is the largest market for balloon expandable stents, accounting for approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on research and development. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies, enhancing market dynamics. The United States leads the North American market, with significant contributions from key players such as Abbott Laboratories and Boston Scientific Corporation. The competitive landscape is characterized by continuous product innovations and strategic partnerships. Canada also plays a vital role, with increasing investments in healthcare technology and a growing demand for minimally invasive procedures, contributing to the overall market growth.

Europe : Emerging Regulatory Frameworks

Europe is the second-largest market for balloon expandable stents, holding around 30% of the global market share. The region's growth is propelled by an aging population, rising healthcare expenditure, and favorable regulatory frameworks that encourage innovation. The European Medicines Agency (EMA) plays a crucial role in ensuring the safety and efficacy of medical devices, which boosts consumer confidence and market demand. Leading countries in Europe include Germany, France, and the UK, where major players like B. Braun Melsungen AG and Medtronic plc are actively expanding their market presence. The competitive landscape is marked by a mix of established companies and emerging startups, focusing on advanced technologies and patient-centric solutions. Collaborative efforts among stakeholders further enhance the region's market potential.

Asia-Pacific : Rapidly Growing Market Potential

Asia-Pacific is witnessing rapid growth in the balloon expandable stent market, accounting for approximately 20% of the global share. The region's expansion is driven by increasing healthcare investments, rising awareness of cardiovascular diseases, and a growing middle-class population seeking advanced medical solutions. Countries like China and India are at the forefront, supported by government initiatives aimed at improving healthcare access and affordability. China is the largest market in the region, with significant contributions from local manufacturers and international players like Terumo Corporation. The competitive landscape is evolving, with a focus on innovation and cost-effective solutions. India is also emerging as a key player, with a growing demand for minimally invasive procedures and a robust healthcare infrastructure, further driving market growth.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region is gradually emerging in the balloon expandable stent market, holding about 5% of the global share. The growth is primarily driven by increasing investments in healthcare infrastructure, rising prevalence of cardiovascular diseases, and a growing awareness of advanced medical technologies. Governments are actively promoting healthcare reforms, which are expected to enhance market dynamics in the coming years. Leading countries in this region include South Africa and the UAE, where there is a growing presence of key players like Cardinal Health, Inc. and Cook Medical Incorporated. The competitive landscape is characterized by a mix of local and international companies, focusing on expanding their product offerings and improving healthcare access. The region's potential for growth remains significant, with ongoing investments in healthcare facilities and technology.

Balloon Expandable Stent Market Regional Image

Key Players and Competitive Insights

The competitive insights of the Balloon Expandable Stent Market reveal a landscape characterized by rapid technological advancements and a growing demand for minimally invasive surgical procedures. This market has evolved significantly over the past few years due to an increase in cardiovascular diseases and the aging population, leading to a higher requirement for effective stenting solutions. 

Companies in this sector are focusing on product innovation, enhancing stent design, materials, and delivery systems to improve patient outcomes and procedural efficiency. The competitive rivalry is characterized by mergers, collaborations, and strategic partnerships, driving companies to leverage their strengths and foster market growth to meet the rising patient needs. As a result, a combination of key players is continuously innovating to maintain their competitive edge and capture a larger market share. In the Balloon Expandable Stent Market, St. Jude Medical has established a formidable presence thanks to its commitment to research and development.

The company has made significant strides in advancing technologies that address complex cardiovascular conditions. With a broad portfolio of balloon-expandable stents, St. Jude Medical focuses on delivering high performance and reliability, which enhances procedural efficiency and provides improved patient outcomes in interventional cardiology. 

The integration of unique coating technologies and innovative designs in its stents allows St. Jude Medical to offer products that are tailored to the specific needs of healthcare providers and patients alike. Additionally, the company's strong track record in regulatory approvals and market penetration reinforces its position as a reliable leader in the field, facilitating expansion into emerging markets and enhancing its competitive advantage. Terumo Corporation plays a significant role in the Balloon Expandable Stent Market, known for its commitment to improving patient care through innovation and high-quality product offerings.

The company has effectively capitalized on its extensive research capabilities to develop innovative balloon-expandable stent systems that prioritize safety and efficacy. 

Terumo Corporation's stents are designed with advanced materials and technologies that enhance the deployment process and ensure optimal vascular support. The company’s focus on strategic partnerships and collaborations with healthcare professionals positions it well in the market, fostering trust and credibility among stakeholders. Furthermore, Terumo Corporation's dedication to achieving high standards in manufacturing and quality assurance not only bolsters its reputation but also allows for the continued expansion of its market presence, thus solidifying its status among key players in this highly competitive landscape.

Key Companies in the Balloon Expandable Stent Market market include

Industry Developments

Recent developments in the Balloon Expandable Stent Market have demonstrated significant activity among key players such as St. Jude Medical, Abbott Laboratories, Boston Scientific, and Medtronic. These companies are actively advancing technology and enhancing product lines to cater to the growing demand for minimally invasive vascular procedures. Current affairs indicate that major corporations like Terumo Corporation and B. Braun Melsungen are investing in research and development for next-generation stents that improve patient outcomes and reduce recovery times. 

Furthermore, the market has seen noteworthy merger and acquisition activity, including companies looking to expand their product portfolios and geographic reach. Specifically, some companies are aligning with microvascular firms to leverage expertise in innovative stent technologies. The valuation of companies like Merit Medical Systems and MicroPort Scientific is benefitting from increases in market share due to successful product launches and strategic partnerships. The evolving landscape underscores how advancements in materials and design are driving growth within this sector, indicating that the demand for balloon expandable stents remains robust as healthcare providers seek efficient and effective solutions for treating cardiovascular issues.

Future Outlook

Balloon Expandable Stent Market Future Outlook

The Balloon Expandable Stent Market is projected to grow at a 3.73% CAGR from 2024 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.

New opportunities lie in:

  • Development of biodegradable stents for enhanced patient outcomes.
  • Expansion into emerging markets with tailored product offerings.
  • Investment in telehealth solutions for remote stent monitoring.

By 2035, the market is expected to solidify its position as a leader in cardiovascular interventions.

Market Segmentation

Balloon Expandable Stent Market Type Outlook

  • Drug-Eluting Stents
  • Bare-Metal Stents
  • Bioresorbable Stents

Balloon Expandable Stent Market End Use Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Balloon Expandable Stent Market Material Outlook

  • Metal
  • Polymer
  • Composite

Balloon Expandable Stent Market Application Outlook

  • Coronary Artery Disease
  • Peripheral Artery Disease
  • Valve Replacement

Report Scope

MARKET SIZE 20244.8(USD Billion)
MARKET SIZE 20254.979(USD Billion)
MARKET SIZE 20357.182(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)3.73% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesAdvancements in biocompatible materials enhance performance in the Balloon Expandable Stent Market.
Key Market DynamicsTechnological advancements and regulatory changes drive innovation and competition in the Balloon Expandable Stent Market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

Leave a Comment

FAQs

What is the projected market valuation of the Balloon Expandable Stent Market in 2035?

The projected market valuation for the Balloon Expandable Stent Market in 2035 is 7.182 USD Billion.

What was the market valuation of the Balloon Expandable Stent Market in 2024?

The overall market valuation of the Balloon Expandable Stent Market was 4.8 USD Billion in 2024.

What is the expected CAGR for the Balloon Expandable Stent Market from 2025 to 2035?

The expected CAGR for the Balloon Expandable Stent Market during the forecast period 2025 - 2035 is 3.73%.

Which application segment is projected to have the highest valuation in 2035?

The Coronary Artery Disease application segment is projected to reach 2.83 USD Billion by 2035.

What are the projected valuations for Drug-Eluting Stents by 2035?

The projected valuation for Drug-Eluting Stents is expected to be 3.5 USD Billion in 2035.

Which material segment is anticipated to grow the most by 2035?

The Metal material segment is anticipated to grow to 3.5 USD Billion by 2035.

What is the expected valuation for the Peripheral Artery Disease application segment in 2035?

The expected valuation for the Peripheral Artery Disease application segment is 2.09 USD Billion in 2035.

How does the market for Bare-Metal Stents compare to Bioresorbable Stents in 2035?

In 2035, the market for Bare-Metal Stents is projected to be 2.2 USD Billion, while Bioresorbable Stents are expected to reach 1.5 USD Billion.

Which end-use segment is projected to have the highest valuation in 2035?

The Hospitals end-use segment is projected to reach 3.5 USD Billion by 2035.

Who are the key players in the Balloon Expandable Stent Market?

Key players in the Balloon Expandable Stent Market include Abbott Laboratories, Boston Scientific Corporation, and Medtronic plc, among others.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions